Senzime
5,8
SEK
-1,69 %
SEZI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Mindre end 1K følgere
-1,69%
+2,29%
+5,45%
-8,66%
-29,95%
-25,16%
-71,45%
-66,59%
-2,27%
Senzime is a medical technology company. The company develops technology solutions that make it possible to follow biochemical and physiological processes before, during and after surgery. The portfolio includes systems used to automate and measure the substances glucose and lactate in blood and tissues. In addition to the main services, digital systems are also offered and developed for monitoring patients' conditions during anesthesia treatment. The company's head office is located in Uppsala.
Læs mereMarkedsværdi
772,41 mio. SEK
Aktieomsætning
235,91 t SEK
Omsætning
35,75 mio.
EBIT %
-384,22 %
P/E
-
Udbytteafkast, %
-
Finanskalender
17.2
2025
Årsrapport '24
7.5
2025
Delårsrapport Q1'25
19.5
2025
Generalforsamling '25
ViserAlle indholdstyper
Carnegie Access: Senzime: Several new orders announced
Senzime secures multiple new hospital contracts for its next-generation TetraGraph system
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools